ஒத்திசைவு மருந்துகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஒத்திசைவு மருந்துகள். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஒத்திசைவு மருந்துகள் Today - Breaking & Trending Today

Concord Drugs Ltd Q1FY22 net profit at Rs. 68.77 lakhs

Concord Drugs Ltd Q1FY22 net profit at Rs. 68.77 lakhs
equitybulls.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from equitybulls.com Daily Mail and Mail on Sunday newspapers.

Concord Drugs , Concord Drugs Ltd , Time Zone , Drugs Limited , Concord Drugs Limited , ஒத்திசைவு மருந்துகள் , ஒத்திசைவு மருந்துகள் லிமிடெட் , நேரம் ஸோந் , மருந்துகள் வரையறுக்கப்பட்டவை ,

Concord Drugs standalone net profit rises 183.33% in the March 2021 quarter

Concord Drugs standalone net profit rises 183.33% in the March 2021 quarter
business-standard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from business-standard.com Daily Mail and Mail on Sunday newspapers.

Particularsquarter Endedyear Endedmar , Concord Drugs , Quarter Endedyear , Var Sales , Capital Market , ஒத்திசைவு மருந்துகள் , வார் விற்பனை , மூலதனம் சந்தை ,

Markets likely to witness lacklustre trade; eyes RBI's monetary policy

Markets likely to witness lacklustre trade; eyes RBI’s monetary policy
April 07, 2021
×
Stocks to watch out for today: Barbeque-Nation, RIL, Cholamandalam Investment, Axis Bank, M&M and Concord Drugs
Markets are likely to witness another lacklustre trading on Wednesday, even as the Reserve Bank will unveil its monetary policy in the afternoon. However, global stocks continue to unsupportive of bulls, with the US and some Asian markets being listless.
SGX Nifty at 14,760 (8 am IST) indicates a flat opening, as Nifty futures on Tuesday closed at 14,750. While Dow Jones, Nasdaq and S&P 500 closed marginally lower overnight, Asian markets such as Japan s Nikkei, China s Shanghai, Australia s ASX and Korea s Kospi were little changed in the morning. ....

Andhra Pradesh , India General , Bharti Airtel , Nagaraj Shetti , Hayatnagar Mandal , Dow Jones , Vinod Nair , Concord Drugs , Axis Bank , Head Of Research , Macrotech Developers , Max Financial Services , Technical Research Analyst , Reliance Jio Infocomm Ltd , Renewable Energy , Axis Capital , Lodha Developers , Syrup Division , Development Authority Of India , Company Limited Chola , Max Life Insurance Company , Head Of Research At Geojit Financial Services , Murugappa Group , Mahindra Susten Private , Nation Hospitality Ltd , Mahindra Solarize Private ,

Concord Drugs Limited starts dry syrup division

Concord Drugs Limited starts dry syrup division
Posted On:
2021-04-06 10:19:35
(Time Zone: Arizona, USA)
Concord Drugs Limited has started the Dry Syrup Division at its existing plant situated at Survey No.249, Brahmanapally Village, Hayatnagar Mandal - 501511, Telangana.
Shares of Concord Drugs Ltd was last trading in BSE at Rs.31.05 as compared to the previous close of Rs. 29.6. The total number of shares traded during the day was 9949 in over 30 trades.
The stock hit an intraday high of Rs. 31.05 and intraday low of 29.65. The net turnover during the day was Rs. 302416.
Source: ....

United States , Andhra Pradesh , Hayatnagar Mandal , Concord Drugs , Concord Drugs Ltd , Syrup Division , Drugs Limited , Time Zone , Dry Syrup Division , Brahmanapally Village , ஒன்றுபட்டது மாநிலங்களில் , ஆந்திரா பிரதேஷ் , ஹயத்நகர் மண்டல் , ஒத்திசைவு மருந்துகள் , ஒத்திசைவு மருந்துகள் லிமிடெட் , சிரப் பிரிவு , மருந்துகள் வரையறுக்கப்பட்டவை , நேரம் ஸோந் , உலர்ந்த சிரப் பிரிவு , பிராமணபள்ளி கிராமம் ,

Rakesh Jhunjhunwala pares stake in this smallcap stock

Rakesh Jhunjhunwala pares stake in this smallcap stock
SECTIONS
Last Updated: Mar 03, 2021, 08:55 AM IST
Share
Synopsis
Jhunjhunwala sold 150,770 shares of the company at Rs 1,205.19 per share while Rare Investments dumped 387,727 shares at Rs 1,205.42 per share.
ETMarkets.com
At the same time, Plutus Wealth Management bought 475,000 shares of Ion Exchange at Rs 1,220.75 per share.
Related
NSE
Ion Exchange, according to bulk deal data available on the BSE on Tuesday.
The ace investor sold 150,770 shares of the company at Rs 1,205.19 per share while Rare Investments dumped 387,727 shares at Rs 1,205.42 per share. At the same time, Plutus Wealth Management bought 475,000 shares of Ion Exchange at Rs 1,220.75 per share. ....

Nagi Reddy Selam , Rakesh Jhunjhunwala , Rashi Gupta , Ion Exchange At Rs , Rare Investments , Plutus Wealth Management , Ion Exchange , Concord Drugs , Nagi Reddy , Bulk Deals , நாகி சிவப்பு சேலம் , ராகேஷ் ஜுன்ஜுன்வாலா , ரஷி குப்தா , அயன் பரிமாற்றம் இல் ர்ச் , ரேர் முதலீடுகள் , பிழுத்துச் செல்வம் மேலாண்மை , அயன் பரிமாற்றம் , ஒத்திசைவு மருந்துகள் , நாகி சிவப்பு , மொத்தமாக ஒப்பந்தங்கள் ,